A pre-clinical organoid model to select suitable bladder cancer patients for targeting EZH2 treatment

被引：0
|
作者：
Zhao, H. [1 ]
Liao, J. [2 ]
Liu, K. [1 ]
Chen, X. [1 ]
Wu, H. [1 ]
Chiu, P. K-F [1 ]
Ng, C-F [1 ]
Teoh, J. Y-C [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Peoples R China
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0592
引用
收藏
页码：S1501 / S1501
页数：1
相关论文
共 50 条
  • [1] A PRE-CLINICAL ORGANOID MODEL TO SELECT SUITABLE BLADDER CANCER PATIENTS FOR TARGETING EZH2 TREATMENT
    Zhao, Hongda
    Liao, Jason
    Liu, Kang
    Chen, Xuan
    Wu, Hongwei
    Chiu, Peter Ka-Fung Chiu
    Ng, Chi-Fai
    Teoh, Jeremy Yuen-Chun
    JOURNAL OF UROLOGY, 2024, 211 (05): : E232 - E232
  • [2] Targeting histone methyltransferase EZH2 as cancer treatment
    Kondo, Yutaka
    JOURNAL OF BIOCHEMISTRY, 2014, 156 (05): : 249 - 257
  • [3] EZH2 targeting to improve the sensitivity of acquired radio-resistance bladder cancer cells
    Zhang, Xiangyan
    Ma, Xiangli
    Wang, Quanxin
    Kong, Zhaolu
    TRANSLATIONAL ONCOLOGY, 2022, 16
  • [4] CANCER VACCINE TARGETING MYB IN COLORECTAL CANCER: FROM PRE-CLINICAL MODEL TO CLINICAL TRIAL
    Toan Pham
    Sampurno, Shienny
    Pereira, Lloyd
    Roth, Sara
    Narasimhan, Vignesh
    Carpinteri, Sandra
    Heriot, Alexander
    Desai, Jayesh
    Ramsay, Robert G.
    GASTROENTEROLOGY, 2018, 154 (06) : S1269 - S1269
  • [5] An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients
    Crea, F.
    Fornaro, L.
    Paolicchi, E.
    Masi, G.
    Frumento, P.
    Loupakis, F.
    Salvatore, L.
    Cremolini, C.
    Schirripa, M.
    Graziano, F.
    Ronzoni, M.
    Ricci, V.
    Farrar, W. L.
    Falcone, A.
    Danesi, R.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1207 - 1213
  • [6] Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells
    Wang, H. F.
    Yang, H.
    Hu, L. B.
    Lei, Y. H.
    Qin, Y.
    Li, J.
    Bi, C. W.
    Wang, J. S.
    Huo, Q.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (04) : 9939 - 9950
  • [7] TARGETING FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR)-3 IN BLADDER CANCER: PRE-CLINICAL PROOF OF PRINCIPLE
    Gust, Kilian M.
    McConkey, David J.
    Hegarty, Paul K.
    Bondaruk, Jolanta E.
    Czerniak, Bogdan A.
    Dinney, Colin P. N.
    Black, Peter C.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E544 - E544
  • [8] miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling
    Guo, Yuwen
    Ying, Liang
    Tian, Ye
    Yang, Peiqian
    Zhu, Yichen
    Wang, Zhipeng
    Qiu, Feng
    Lin, Jun
    FEBS JOURNAL, 2013, 280 (18) : 4531 - 4538
  • [9] APPLICATION OF BLADDER CANCER PATIENT-DERIVED ORGANOIDS AS PRE-CLINICAL MODEL FOR PERSONALIZED MEDICINE
    Minoli, Martina
    Kiener, Mirjam
    Cantore, Thomas
    Fedrizzi, Tarcisio
    Gasparini, Paola
    Demichelis, Francesca
    Thalmann, George N.
    Seiler-Blarer, Roland
    Kruithof-de Julio, Marianna
    JOURNAL OF UROLOGY, 2022, 207 (05): : E79 - E79
  • [10] A tailored 3-dimensional Pre-clinical model for muscle-invasive bladder cancer
    Sharma, N.
    Sharma, A.
    Scott, H.
    Yeh, S.
    Kiltie, A.
    Hamdy, F.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2014, 8 : 205 - 205
12345